Viewing Study NCT06229366


Ignite Creation Date: 2025-12-24 @ 4:03 PM
Ignite Modification Date: 2026-02-20 @ 6:41 PM
Study NCT ID: NCT06229366
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-22
First Post: 2024-01-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module